Patent Assignment
Reel/Frame 016580/0695
Change of Name
Recorded: 2005-09-27
Pages: 4
Assignor
RIBAPHARM INC.
Executed: 2005-04-05
Assignee
VALEANT RESEARCH & DEVELOPMENT
3300 HYLAND AVENUE, COSTA MESA, CALIFORNIA, 92626
Covered Properties
(6)
2'-Beta-Modified-6-Substituted Adenosine Analogs and Their Use as Antiviral Agents
PCT:
PCT/US2002/034026 ↗
Cytidine Analogs and Methods of Use
PCT:
PCT/US2003/006992 ↗
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
PCT:
PCT/US2004/001125 ↗
G-Rich Oligo Aptamers and Methods of Modulating an Immune Response
Patent:
6,994,959 →
Application:
09/331,204 →
Treatment of Viral Infections Using the L-Isomer of Ribavirin
Patent:
6,518,253 →
Application:
09/471,513 →
Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections
Application:
10/418,662 →
Publication:
US 2006/0074035
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 8, 2000
From: TAM, ROBERT
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 010587/0399 →
Assignment of Assignor's Interest
Aug 16, 2004
From: TAM, ROBERT
To: RIBAPHARM INC.
Reel/Frame 014993/0993 →
Assignment of Assignor's Interest
Feb 22, 2005
From: RAMASAMY, KANDA S; SHAW, STEPHANIE; AN, HAOYUN
To: RIBAPHARM INC.
Reel/Frame 015697/0843 →
Assignment of Assignor's Interest
Feb 25, 2005
From: GIRARDET, JEAN-LUC; KOH, YUNG-HYO; HONG, ZHI; AN, HAOYUN
To: RIBAPHARM INC.
Reel/Frame 015704/0487 →
Assignment of Assignor's Interest
Feb 25, 2005
From: HONG, ZHI; ZHONG, WEIDONG; BARAWKAR, DINESH; AN, HAOYUN
To: RIBAPHARM INC.
Reel/Frame 015704/0445 →
Contribution Agreement
Mar 27, 2005
From: ICN PHARMACEUTICALS, INC.
To: RIBAPHARM INC.
Reel/Frame 015819/0595 →
Assignment of Assignor's Interest
Aug 2, 2005
From: AN, HAOYUN; DING, YILI; SHAW, STEPHANIE Z; HONG, ZHI
To: RIBAPHARM INC.
Reel/Frame 016342/0534 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Security Agreement
Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest
Jul 19, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043045/0913 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →